GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 24401 - 24450 of 39437 in total
PDB ID UniProt ID Title ▲ Descriptor
8OLT Q9CQ91 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9CQY9 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9CQ54 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q99LY9 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT P0DN34 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT O09111 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9CQH3 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q3UIU2 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9CPU2 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9CQZ6 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9D6J5 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9CQC7 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9CQJ8 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT 8OLT Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9DCS9 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q7TMF3 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q9Z1P6 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
8OLT Q8BK30 Mitochondrial complex I from Mus musculus in the active state bound with piericidin A
5NJP P00698 Mix-and-diffuse serial synchrotron crystallography: structure of N,N',N''-Triacetylchitotriose bound to Lysozyme with 1s time-delay, phased with 1HEW
5NJQ P00698 Mix-and-diffuse serial synchrotron crystallography: structure of N,N',N''-Triacetylchitotriose bound to Lysozyme with 1s time-delay, phased with 4ET8
5NJS P00698 Mix-and-diffuse serial synchrotron crystallography: structure of N,N',N''-Triacetylchitotriose bound to Lysozyme with 50s time-delay, phased with 1HEW
5NJR P00698 Mix-and-diffuse serial synchrotron crystallography: structure of N,N',N''-Triacetylchitotriose bound to Lysozyme with 50s time-delay, phased with 4ET8
6OR2 A0QP27 MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
3I6N P80025 Mode of Binding of the Tuberculosis Prodrug Isoniazid to Peroxidases: Crystal Structure of Bovine Lactoperoxidase with Isoniazid at 2.7 Resolution
5HPW A3F9D6 Mode of binding of antithyroid drug, propylthiouracil to lactoperoxidase: Binding studies and structure determination
3GCJ P80025 Mode of ligand binding and assignment of subsites in mammalian peroxidases: crystal structure of lactoperoxidase complexes with acetyl salycylic acid, salicylhydroxamic acid and benzylhydroxamic acid
3GCK P80025 Mode of ligand binding and assignment of subsites in mammalian peroxidases: crystal structure of lactoperoxidase complexes with acetyl salycylic acid, salicylhydroxamic acid and benzylhydroxamic acid
3GCL P80025 Mode of ligand binding and assignment of subsites in mammalian peroxidases: crystal structure of lactoperoxidase complexes with acetyl salycylic acid, salicylhydroxamic acid and benzylhydroxamic acid
3J2Q P00451 Model of membrane-bound factor VIII organized in 2D crystals Coagulation factor VIII heavy chain, Coagulation factor VIII light chain
6ORQ 6ORQ Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab275MUR Envelope glycoprotein gp41, Envelope glycoprotein gp120, Ab275MUR antibody Fab heavy chain, Ab275MUR antibody Fab light chain
6ORO 6ORO Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab874NHP RC1 variant of HIV-1 Env glycoprotein gp41, RC1 variant of HIV-1 Env glycoprotein gp120, Ab874NHP antibody Fab heavy chain, Ab874NHP antibody Fab light chain
6ORP 6ORP Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP Envelope glycoprotein gp41, Envelope glycoprotein gp120, Ab897NHP antibody Fab heavy chain, Ab897NHP antibody Fab light chain
6ORN 6ORN Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain
5U66 Q6MZV7 Modified single helix from the B-domain of protein A bound to IgG1 Fc
5U66 5U66 Modified single helix from the B-domain of protein A bound to IgG1 Fc
6TMR P0C572 Mokola virus glycoprotein, monomeric post-fusion conformation Glycoprotein
3WLW P04626 Molecular Architecture of the ErbB2 Extracellular Domain Homodimer Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Antibody H Chain, Antibody L Chain
3WLW 3WLW Molecular Architecture of the ErbB2 Extracellular Domain Homodimer Receptor tyrosine-protein kinase erbB-2 (E.C.2.7.10.1), Antibody H Chain, Antibody L Chain
3OHX P01024 Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b Complement C3, Staphylococcal complement inhibitor
3OHX Q931M7 Molecular Basis for Complement Recognition and Inhibition Determined by Crystallographic Studies of the Staphylococcal Complement Inhibitor (SCIN) Bound to C3c and C3b Complement C3, Staphylococcal complement inhibitor
3V1W P07221 Molecular Basis for Multiple Ligand Binding of Calsequestrin and Potential Inhibition by Caffeine and Gallocatecin
7C01 P0DTC2 Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD
7C01 7C01 Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD
5EN2 5EN2 Molecular basis for antibody-mediated neutralization of New World hemorrhagic fever mammarenaviruses
5EN2 P26313 Molecular basis for antibody-mediated neutralization of New World hemorrhagic fever mammarenaviruses
6LR4 Q92542 Molecular basis for inhibition of human gamma-secretase by small molecule Nicastrin, Presenilin-1 (E.C.3.4.23.-), Gamma-secretase subunit APH-1A, Gamma-secretase subunit PEN-2
6LR4 P49768 Molecular basis for inhibition of human gamma-secretase by small molecule Nicastrin, Presenilin-1 (E.C.3.4.23.-), Gamma-secretase subunit APH-1A, Gamma-secretase subunit PEN-2
6LR4 Q96BI3 Molecular basis for inhibition of human gamma-secretase by small molecule Nicastrin, Presenilin-1 (E.C.3.4.23.-), Gamma-secretase subunit APH-1A, Gamma-secretase subunit PEN-2
6LR4 Q9NZ42 Molecular basis for inhibition of human gamma-secretase by small molecule Nicastrin, Presenilin-1 (E.C.3.4.23.-), Gamma-secretase subunit APH-1A, Gamma-secretase subunit PEN-2
8BQU Q91184 Molecular basis of ZP3/ZP1 heteropolymerization: crystal structure of a native vertebrate egg coat filament

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024